Brought to you by:
HIFLO RCT finds increased wound closure, high-quality healing using mVASC microvascular tissue graft
Treatment with the mVASC microvascular tissue graft product (MicroVascular Tissues) results in superior wound closure compared to standard of care alone, the first randomized controlled trial using microvascular elements to treat microvascular dysfunction—the HIFLO trial—finds. Presented at the Symposium on…
Correct billing in severe trauma cases can be complicated
The management of the severely injured trauma patient often requires delicate coordination among multiple specialties, and multiple separate operative procedures are often necessary. In particular, the clinical management of concomitant vascular and orthopedic injuries can be complicated. As a practical…
Active stent-graft fixation below the renal arteries may have the least effect on aortic neck degeneration, study finds
Stent grafts with active fixation below the renal arteries as well as oversizing by less than 10% seem to have the least effect on aortic neck degeneration over time, according to a research team who conducted a retrospective review of…
‘Smile’ to benefit SVS Foundation
The holidays are close upon us, and many Society for Vascular Surgery (SVS) members will be shopping online this month and next. The COVID-19 pandemic has, in fact, prompted many people to do even more shopping online then before. Those…
Healthcare on a precipice: SVS PAC stands ready to fight coming challenges
Since 2002, the SVS Political Action Committee (PAC) has been a vehicle for advocacy specifically for vascular surgeons. As the only voice geared for vascular surgeons in Washington, D.C., it plays an instrumental role in championing pressing concerns that matter…
VOYAGER PAD: Rivaroxaban plus aspirin versus aspirin alone among CLTI patients undergoing revascularization reduced risk of adverse outcomes at three years
In one of the latest sub-analyses from the VOYAGER PAD trial, investigators found that rivaroxaban plus aspirin versus aspirin alone in the high-risk population of patients with critical limb-threatening ischemia (CLTI) undergoing lower-extremity revascularization reduced the risk of a first…
SVS members in the news
Richard Lynn, MD, a vascular surgeon from Palm Beach, Florida, has been elected second vice-president-elect of the American College of Surgeons (ACS). Alan Dardik, MD, of Yale University School of Medicine, New Haven, Connecticut, and Andres Schanzer, MD, of the…
Dig deep this Giving Tuesday
Will you give on Giving Tuesday? This will be the SVS Foundation’s third year marking the annual global day of giving—Dec. 1, this year—which follows Thanksgiving and the big shopping days of Black Friday and Cyber Monday. The day is…
Diabetes Awareness Month: The utility of SVS branding fliers for diabetic foot ulcers
November is Diabetes Awareness Month. The Branding Toolkit can help SVS members promote the valuable care they provide those with the disease. One of the three customizable condition fliers currently available covers diabetic foot ulcers (the other two address abdominal…
SVS details opposition, support to CMS proposed rules
The Society for Vascular Surgery (SVS) has submitted comment letters to the Centers for Medicare & Medicaid Services (CMS) on two proposed rules that directly affect SVS members: the Medicare Physician Fee Schedule and the Hospital Outpatient Prospective Payment and…